$LBUY
LEAFBUYER TECHNOLOGIES, INC. Stock $lbuy

$lbuy Overview Financials Valuation SEC Filings Company Website

2024 Q3 Form 10-Q Financial Statement

#000147793224005855 Filed on September 20, 2024

Income Statement

Concept	2024 Q3	2024 Q1	2023
Revenue	$1.609M	$1.497M	$5.091M
YoY Change	37.61%	16.37%	33.72%
Cost Of Revenue	$860.2K	$933.7K	$2.843M
YoY Change	5.76%	21.3%	4.76%
Gross Profit	$749.3K	$563.1K	$2.248M
YoY Change	110.31%	9.03%	105.61%
Gross Profit Margin	46.55%	37.62%	44.16%
Selling, General & Admin	$716.8K	$398.1K	$2.668M
YoY Change	60.76%	19.8%	-1.11%
% of Gross Profit	95.66%	70.7%	118.69%
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization		$181.1K	$720.0K
YoY Change		0.0%	-0.61%
% of Gross Profit		32.17%	32.03%
Operating Expenses	$716.8K	$702.5K	$2.668M
YoY Change	-0.07%	7.82%	-1.11%
Operating Profit	$32.49K	-$139.4K	-$420.2K
YoY Change	-109.0%	3.21%	-73.82%
Interest Expense	$20.99K	$32.22K	-$170.0K
YoY Change	-44.22%	-9.02%	-108.49%
% of Operating Profit	64.6%
Other Income/Expense, Net	-$20.99K	$0.00	$0.00
YoY Change		-100.0%
Pretax Income		-$171.7K	-$590.0K
YoY Change		0.7%	-161.73%
Income Tax	$0.00		$0.00
% Of Pretax Income
Net Earnings	$11.50K	-$171.6K	-$585.2K
YoY Change	-102.89%	0.7%	-161.23%
Net Earnings / Revenue	0.71%	-11.47%	-11.5%
Basic Earnings Per Share		$0.00	$0.00
Diluted Earnings Per Share		$0.00	-$0.01
COMMON SHARES
Basic Shares Outstanding	100.1M shares	99.43M shares	95.92M shares
Diluted Shares Outstanding

Balance Sheet

Concept	2024 Q3	2024 Q1	2023
SHORT-TERM ASSETS
Cash & Short-Term Investments		$155.9K	$450.0K
YoY Change		-64.15%	22.53%
Cash & Equivalents	$231.4K	$155.9K	$450.0K
Short-Term Investments
Other Short-Term Assets		$21.00K	$30.00K
YoY Change		-23.3%	29.81%
Inventory
Prepaid Expenses
Receivables	$91.03K	$194.4K	$140.0K
Other Receivables		$0.00	$0.00
Total Short-Term Assets	$329.6K	$371.4K	$610.0K
YoY Change	-4.69%	-29.58%	45.43%
LONG-TERM ASSETS
Property, Plant & Equipment		$1.500K	$0.00
YoY Change		-99.89%	-100.0%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets
YoY Change
Total Long-Term Assets	$477.9K	$681.7K	$1.230M
YoY Change	-54.22%	-51.52%	-36.91%
TOTAL ASSETS
Total Short-Term Assets	$329.6K	$371.4K	$610.0K
Total Long-Term Assets	$477.9K	$681.7K	$1.230M
Total Assets	$807.5K	$1.053M	$1.840M
YoY Change	-41.9%	-45.54%	-22.33%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$144.4K	$227.8K	$310.0K
YoY Change	-53.74%	-19.83%	-14.11%
Accrued Expenses	$967.0K	$1.075M	$1.170M
YoY Change	-11.23%	-4.67%	-0.68%
Deferred Revenue
YoY Change
Short-Term Debt		$0.00	$0.00
YoY Change
Long-Term Debt Due		$1.067M	$1.140M
YoY Change		-28.06%	-34.1%
Total Short-Term Liabilities	$2.041M	$2.383M	$2.630M
YoY Change	-18.67%	-17.84%	-19.85%
LONG-TERM LIABILITIES
Long-Term Debt		$456.1K	$490.0K
YoY Change		-6.02%	-2.0%
Other Long-Term Liabilities
YoY Change
Total Long-Term Liabilities		$456.1K	$490.0K
YoY Change		-6.02%	-2.0%
TOTAL LIABILITIES
Total Short-Term Liabilities	$2.041M	$2.383M	$2.630M
Total Long-Term Liabilities		$456.1K	$490.0K
Total Liabilities	$2.454M	$2.839M	$3.110M
YoY Change	-17.68%	-16.14%	-17.76%
SHAREHOLDERS EQUITY
Retained Earnings	-$25.13M	-$25.23M
YoY Change	1.21%	3.95%
Common Stock	$100.1K	$100.1K
YoY Change	0.65%	4.86%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity	-$1.646M	-$1.786M	-$1.280M
YoY Change
Total Liabilities & Shareholders Equity	$807.5K	$1.053M	$1.840M
YoY Change	-41.9%	-45.54%	-22.33%

Cashflow Statement

Concept	2024 Q3	2024 Q1	2023
OPERATING ACTIVITIES
Net Income	$11.50K	-$171.6K	-$585.2K
YoY Change	-102.89%	0.7%	-161.23%
Depreciation, Depletion And Amortization		$181.1K	$720.0K
YoY Change		0.0%	-0.61%
Cash From Operating Activities	$211.2K	-$53.43K	$422.6K
YoY Change	-213.85%	-121.13%	-233.14%
INVESTING ACTIVITIES
Capital Expenditures			$0.00
YoY Change
Acquisitions
YoY Change
Other Investing Activities		$0.00
YoY Change
Cash From Investing Activities		$0.00	$0.00
YoY Change
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net			$0.00
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	-$145.1K	-17.31K	$0.00
YoY Change	153.23%	-85.1%
NET CHANGE
Cash From Operating Activities	$211.2K	-53.43K	$422.6K
Cash From Investing Activities		0.000	$0.00
Cash From Financing Activities	-$145.1K	-17.31K	$0.00
Net Change In Cash	$66.05K	-70.74K	$78.48K
YoY Change	-127.2%	-151.76%	-124.73%
FREE CASH FLOW
Cash From Operating Activities	$211.2K	-$53.43K	$422.6K
Capital Expenditures			$0.00
Free Cash Flow			$422.6K
YoY Change			-233.14%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
CY2024Q1	us-gaap	Assets Current AssetsCurrent	371362	usd
CY2024Q1	us-gaap	Assets Assets	1053062	usd
CY2024Q1	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	1074524	usd
CY2024Q1	us-gaap	Deferred Revenue Current DeferredRevenueCurrent	14252	usd
CY2024Q1	us-gaap	Debt Current DebtCurrent	893802	usd
CY2023Q2	us-gaap	Liabilities Current LiabilitiesCurrent	2636303	usd
CY2023Q2	us-gaap	Long Term Debt Noncurrent LongTermDebtNoncurrent	478067	usd
CY2024Q1	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	681700	usd
CY2024Q1	us-gaap	Accounts Payable Current AccountsPayableCurrent	227769	usd
CY2023Q2	us-gaap	Debt Current DebtCurrent	1043802	usd
CY2024Q1	us-gaap	Liabilities Current LiabilitiesCurrent	2383164	usd
CY2024Q1	us-gaap	Liabilities Liabilities	2839298	usd
CY2023Q2	us-gaap	Liabilities Liabilities	3114370	usd
CY2024Q1	us-gaap	Commitments And Contingencies CommitmentsAndContingencies	0	usd
CY2023Q2	us-gaap	Commitments And Contingencies CommitmentsAndContingencies	0	usd
CY2023Q2	us-gaap	Assets Assets	1835499	usd
CY2023Q2	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	1165815	usd
CY2023Q2	us-gaap	Deferred Revenue Current DeferredRevenueCurrent	10029	usd
	us-gaap	Revenues Revenues	4100467	usd
	us-gaap	Revenues Revenues	3763207	usd
CY2024Q1	us-gaap	Cost Of Revenue CostOfRevenue	933663	usd
CY2023Q1	us-gaap	Cost Of Revenue CostOfRevenue	769701	usd
CY2024Q1	us-gaap	Allowance For Doubtful Accounts Receivable AllowanceForDoubtfulAccountsReceivable	49982	usd
CY2023Q2	us-gaap	Allowance For Doubtful Accounts Receivable AllowanceForDoubtfulAccountsReceivable	49982	usd
CY2024Q1	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	194420	usd
CY2023Q2	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	135476	usd
CY2024Q1	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	21000	usd
CY2023Q2	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	29268	usd
CY2023Q2	us-gaap	Assets Current AssetsCurrent	610465	usd
CY2023Q2	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	1225034	usd
CY2023Q2	us-gaap	Accounts Payable Current AccountsPayableCurrent	308840	usd
CY2024Q1	lbuy	Due To Related Party Current DueToRelatedPartyCurrent	172817	usd
CY2023Q2	lbuy	Due To Related Party Current DueToRelatedPartyCurrent	107817	usd
CY2024Q1	us-gaap	Long Term Debt Noncurrent LongTermDebtNoncurrent	456134	usd
CY2023Q2	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	99428575	shares
CY2024Q1	us-gaap	Common Stock Value CommonStockValue	100070	usd
CY2023Q2	us-gaap	Common Stock Value CommonStockValue	99428	usd
CY2024Q1	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	23339320	usd
CY2023Q2	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	23057067	usd
CY2024Q1	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-25225958	usd
CY2023Q2	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-24435698	usd
CY2024Q1	us-gaap	Stockholders Equity StockholdersEquity	-1786236	usd
CY2023Q2	us-gaap	Stockholders Equity StockholdersEquity	-1278871	usd
CY2023Q2	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	1835499	usd
CY2024Q1	us-gaap	Revenues Revenues	1496714	usd
CY2023Q1	us-gaap	Revenues Revenues	1286132	usd
	us-gaap	Cost Of Revenue CostOfRevenue	2732473	usd
	us-gaap	Cost Of Revenue CostOfRevenue	2059325	usd
CY2024Q1	us-gaap	Gross Profit GrossProfit	563051	usd
CY2023Q1	us-gaap	Gross Profit GrossProfit	516431	usd
	us-gaap	Gross Profit GrossProfit	1367994	usd
	us-gaap	Gross Profit GrossProfit	1703882	usd
CY2024Q1	us-gaap	Selling Expense SellingExpense	227328	usd
CY2023Q1	us-gaap	Selling Expense SellingExpense	177812	usd
	us-gaap	Selling Expense SellingExpense	605078	usd
	us-gaap	Selling Expense SellingExpense	509198	usd
CY2024Q1	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	170759	usd
CY2023Q1	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	154487	usd
	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	595000	usd
	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	543231	usd
CY2024Q1	us-gaap	Labor And Related Expense LaborAndRelatedExpense	197514	usd
CY2023Q1	us-gaap	Labor And Related Expense LaborAndRelatedExpense	210827	usd
	us-gaap	Labor And Related Expense LaborAndRelatedExpense	585584	usd
	us-gaap	Labor And Related Expense LaborAndRelatedExpense	594671	usd
CY2024Q1	us-gaap	Share Based Compensation ShareBasedCompensation	106882	usd
	us-gaap	Share Based Compensation ShareBasedCompensation	279855	usd
	us-gaap	Share Based Compensation ShareBasedCompensation	345981	usd
CY2024Q1	us-gaap	Operating Expenses OperatingExpenses	702483	usd
CY2023Q1	us-gaap	Operating Expenses OperatingExpenses	651521	usd
	us-gaap	Operating Expenses OperatingExpenses	2065517	usd
	us-gaap	Operating Expenses OperatingExpenses	1993081	usd
CY2024Q1	us-gaap	Operating Income Loss OperatingIncomeLoss	-139432	usd
CY2023Q1	us-gaap	Operating Income Loss OperatingIncomeLoss	-135090	usd
	us-gaap	Operating Income Loss OperatingIncomeLoss	-697523	usd
	us-gaap	Operating Income Loss OperatingIncomeLoss	-289199	usd
CY2024Q1	us-gaap	Interest Expense InterestExpense	32217	usd
CY2023Q1	us-gaap	Interest Expense InterestExpense	35410	usd
	us-gaap	Interest Expense InterestExpense	92785	usd
	us-gaap	Interest Expense InterestExpense	130544	usd
CY2024Q1	us-gaap	Other Income OtherIncome	0	usd
CY2023Q1	us-gaap	Other Income OtherIncome	42	usd
	us-gaap	Other Income OtherIncome	48	usd
	us-gaap	Other Income OtherIncome	3423	usd
CY2024Q1	us-gaap	Net Income Loss NetIncomeLoss	-171649	usd
CY2023Q1	us-gaap	Net Income Loss NetIncomeLoss	-170458	usd
	us-gaap	Net Income Loss NetIncomeLoss	-790260	usd
	us-gaap	Net Income Loss NetIncomeLoss	-416320	usd
CY2024Q1	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.00
CY2023Q1	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.00
	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.00
CY2024Q1	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	99944894	shares
CY2023Q1	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	95356353	shares
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	99599430	shares
CY2024Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	155942	usd
CY2024Q1	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-25225958	usd
	us-gaap	Use Of Estimates UseOfEstimates	<p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">Management uses estimates and assumptions in preparing these condensed financial statements. Those estimates and assumptions affect the reported amounts of assets and liabilities, the disclosure of contingent assets and liabilities, and the reported revenues and expenses. Examples of estimates include loss contingencies; useful lives of our tangible and intangible assets; allowances for doubtful accounts; and stock-based compensation forfeiture rates. Examples of assumptions include: the elements comprising a software arrangement, including the distinction between upgrades or enhancements and new products; when technological feasibility is achieved for our products; the potential outcome of future tax consequences of events that have been recognized in our financial statements or tax returns. Actual results could differ from those estimates.</p>
CY2024Q1	lbuy	Finite Lived Intangible Assets Software Platform FiniteLivedIntangibleAssetsSoftwarePlatform	4482225	usd
CY2023Q2	lbuy	Finite Lived Intangible Assets Software Platform FiniteLivedIntangibleAssetsSoftwarePlatform	4482225	usd
CY2024Q1	lbuy	Finite Lived Intangible Assets Furniture And Fixtures FiniteLivedIntangibleAssetsFurnitureAndFixtures	1500	usd
CY2023Q2	lbuy	Finite Lived Intangible Assets Furniture And Fixtures FiniteLivedIntangibleAssetsFurnitureAndFixtures	1500	usd
CY2024Q1	us-gaap	Finite Lived Intangible Assets Accumulated Amortization FiniteLivedIntangibleAssetsAccumulatedAmortization	-3802025	usd
CY2023Q2	us-gaap	Finite Lived Intangible Assets Accumulated Amortization FiniteLivedIntangibleAssetsAccumulatedAmortization	-3258691	usd
CY2024Q1	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	681700	usd
CY2023Q2	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	1225034	usd
CY2024Q1	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	181111	usd
CY2023Q1	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	181111	usd
CY2024Q1	us-gaap	Finite Lived Intangible Assets Amortization Expense Next Twelve Months FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths	181111	usd
CY2024Q1	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Two FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo	500589	usd
CY2024Q1	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	681700	usd
CY2024Q1	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	700000000	shares
CY2024Q1	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.001
CY2021Q3	lbuy	Articles Of Amendment ArticlesOfAmendment	the Company filed Articles of Amendment to Amended and Restated Articles of Incorporation with the State of Nevada increasing the number of common shares from 150,000,000 to 700,000,000
CY2024Q1	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	10000000	shares
CY2024Q1	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.001
	us-gaap	Interest Expense Debt InterestExpenseDebt	92785	usd
	us-gaap	Interest Expense Debt InterestExpenseDebt	130544	usd
CY2024Q1	us-gaap	Deposit Liabilities Accrued Interest DepositLiabilitiesAccruedInterest	804181	usd
CY2023Q1	us-gaap	Deposit Liabilities Accrued Interest DepositLiabilitiesAccruedInterest	716351	usd
CY2024Q1	us-gaap	Debt Weighted Average Interest Rate DebtWeightedAverageInterestRate	0.0595	pure
CY2023Q1	us-gaap	Debt Weighted Average Interest Rate DebtWeightedAverageInterestRate	0.0646	pure
CY2024Q1	us-gaap	Notes Payable NotesPayable	1522753	usd
CY2023Q2	us-gaap	Notes Payable NotesPayable	1629686	usd
CY2024Q1	lbuy	Less Current Portion Of Notes Payable LessCurrentPortionOfNotesPayable	1066619	usd
CY2023Q2	lbuy	Less Current Portion Of Notes Payable LessCurrentPortionOfNotesPayable	1151619	usd
CY2024Q1	us-gaap	Notes Payable Current NotesPayableCurrent	456134	usd
CY2023Q2	us-gaap	Notes Payable Current NotesPayableCurrent	478067	usd
CY2023Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Number ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber	662608	shares
CY2023Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue	0.11
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Vested In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod	521238	shares
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Vested In Period Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue	0.11
CY2024Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Number ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber	141370	shares
CY2024Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue	0.11
CY2024Q1	us-gaap	Class Of Warrant Or Right Outstanding ClassOfWarrantOrRightOutstanding	28432941	shares
CY2024Q1	lbuy	Aggregate Intrinsic Value AggregateIntrinsicValue	0	usd
	lbuy	Lessee Operating Lease Term Period LesseeOperatingLeaseTermPeriod	P12M
	us-gaap	Lessee Operating Lease Description LesseeOperatingLeaseDescription	The Company will recognize lease expense on a monthly basis through the life of this lease
	us-gaap	Operating Lease Initial Direct Cost Expense Over Term OperatingLeaseInitialDirectCostExpenseOverTerm	41000	usd
	dei	Entity Central Index Key EntityCentralIndexKey	0001643721
	dei	Amendment Flag AmendmentFlag	false
	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--06-30
	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	Q3
	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2024
CY2024Q1	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	100071075	shares
CY2023Q2	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	99428575	shares
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Forfeited In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod	0	shares
	dei	Document Type DocumentType	10-Q
	dei	Document Quarterly Report DocumentQuarterlyReport	true
	dei	Document Period End Date DocumentPeriodEndDate	2024-03-31
	dei	Document Transition Report DocumentTransitionReport	false
	dei	Entity File Number EntityFileNumber	333-206745
	dei	Entity Registrant Name EntityRegistrantName	LEAFBUYER TECHNOLOGIES, INC.
	dei	Entity Incorporation State Country Code EntityIncorporationStateCountryCode	NV
	dei	Entity Tax Identification Number EntityTaxIdentificationNumber	38-3944821
	dei	Entity Address Address Line1 EntityAddressAddressLine1	6888 S. Clinton Street
	dei	Entity Address Address Line2 EntityAddressAddressLine2	Suite 300
	dei	Entity Address City Or Town EntityAddressCityOrTown	Greenwood Village
	dei	Entity Address State Or Province EntityAddressStateOrProvince	CO
	dei	Entity Address Postal Zip Code EntityAddressPostalZipCode	80112
	dei	City Area Code CityAreaCode	720
	dei	Local Phone Number LocalPhoneNumber	235-0099
	dei	Entity Current Reporting Status EntityCurrentReportingStatus	Yes
	dei	Entity Filer Category EntityFilerCategory	Non-accelerated Filer
	dei	Entity Small Business EntitySmallBusiness	true
	dei	Entity Emerging Growth Company EntityEmergingGrowthCompany	true
	dei	Entity Ex Transition Period EntityExTransitionPeriod	true
	dei	Entity Shell Company EntityShellCompany	false
CY2024Q3	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	100071075	shares
CY2024Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	155942	usd
CY2023Q2	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	445721	usd
CY2023Q2	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.001
CY2023Q2	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	10000000	shares
CY2023Q2	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.001
CY2023Q2	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	700000000	shares
CY2024Q1	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	100071075	shares
CY2024Q1	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	1053062	usd
CY2023Q1	us-gaap	Share Based Compensation ShareBasedCompensation	108395	usd
	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.00
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	95428575	shares
CY2022Q2	us-gaap	Stockholders Equity StockholdersEquity	-1412547	usd
	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation And Exercise Of Stock Options AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationAndExerciseOfStockOptions	273619	usd
	lbuy	Stock Issued During Period Value Issued For Vendor Payments StockIssuedDuringPeriodValueIssuedForVendorPayments	30420	usd
	us-gaap	Stock Issued During Period Value Share Based Compensation StockIssuedDuringPeriodValueShareBasedCompensation	72362	usd
	us-gaap	Net Income Loss NetIncomeLoss	-416320	usd
CY2023Q1	us-gaap	Stockholders Equity StockholdersEquity	-1452466	usd
CY2023Q2	us-gaap	Stockholders Equity StockholdersEquity	-1278871	usd
	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation And Exercise Of Stock Options AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationAndExerciseOfStockOptions	256793	usd
	lbuy	Stock Issued During Period Value Issued For Vendor Payments StockIssuedDuringPeriodValueIssuedForVendorPayments	3040	usd
	us-gaap	Stock Issued During Period Value Share Based Compensation StockIssuedDuringPeriodValueShareBasedCompensation	23062	usd
	us-gaap	Net Income Loss NetIncomeLoss	-790260	usd
CY2024Q1	us-gaap	Stockholders Equity StockholdersEquity	-1786236	usd
	us-gaap	Profit Loss ProfitLoss	-790260	usd
	us-gaap	Profit Loss ProfitLoss	-416320	usd
	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	279855	usd
	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	345981	usd
	us-gaap	Issuance Of Stock And Warrants For Services Or Claims IssuanceOfStockAndWarrantsForServicesOrClaims	3040	usd
	us-gaap	Issuance Of Stock And Warrants For Services Or Claims IssuanceOfStockAndWarrantsForServicesOrClaims	30420	usd
	us-gaap	Depreciation And Amortization DepreciationAndAmortization	543334	usd
	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	58944	usd
	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	-8268	usd
	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	-81071	usd
	us-gaap	Increase Decrease In Accrued Liabilities IncreaseDecreaseInAccruedLiabilities	-87068	usd
	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-182846	usd
	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	329493	usd
	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	0	usd
	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	0	usd
	us-gaap	Proceeds From Bank Debt ProceedsFromBankDebt	65000	usd
	us-gaap	Proceeds From Bank Debt ProceedsFromBankDebt	0	usd
	us-gaap	Repayments Of Debt RepaymentsOfDebt	171933	usd
	us-gaap	Repayments Of Debt RepaymentsOfDebt	261805	usd
	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	-106933	usd
	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	-261805	usd
	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect	-289779	usd
	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect	67688	usd
CY2023Q2	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	445721	usd
CY2022Q2	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	367245	usd
	us-gaap	Interest Paid Net InterestPaidNet	0	usd
	us-gaap	Interest Paid Net InterestPaidNet	0	usd
	us-gaap	Income Taxes Paid Net IncomeTaxesPaidNet	0	usd
	us-gaap	Income Taxes Paid Net IncomeTaxesPaidNet	0	usd
	lbuy	Issuance Of Common Stock For Vendor Payments IssuanceOfCommonStockForVendorPayments	3040	usd
	lbuy	Issuance Of Common Stock For Vendor Payments IssuanceOfCommonStockForVendorPayments	30420	usd
CY2024Q1	lbuy	Working Capital Deficit WorkingCapitalDeficit	-2011802	usd
	us-gaap	Income Loss From Continuing Operations IncomeLossFromContinuingOperations	-697253	usd
CY2024Q1	us-gaap	Allowance For Doubtful Accounts Receivable AllowanceForDoubtfulAccountsReceivable	49982	usd
CY2023Q2	us-gaap	Allowance For Doubtful Accounts Receivable AllowanceForDoubtfulAccountsReceivable	49982	usd
CY2023Q2	us-gaap	Deferred Tax Assets Net DeferredTaxAssetsNet	13035433	usd
CY2024Q1	us-gaap	Deferred Tax Assets Valuation Allowance DeferredTaxAssetsValuationAllowance	13035433	usd
CY2023Q2	us-gaap	Deferred Tax Assets Valuation Allowance DeferredTaxAssetsValuationAllowance	13035433	usd
	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	0	pure
CY2023	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	0	pure
	lbuy	Fixed Assets And Intangible Assets Depreciation Desription FixedAssetsAndIntangibleAssetsDepreciationDesription	acquisition and implementation and enhancement costs during the first 2 year and are depreciated on a straight-line basis over their estimated useful lives of five to seven years
CY2024Q1	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	194420	usd
CY2023Q2	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	135476	usd
CY2023Q2	us-gaap	Deferred Revenue DeferredRevenue	10029	usd
	lbuy	Deferred Revenue Earned DeferredRevenueEarned	8349	usd
	lbuy	Customer Payments Received CustomerPaymentsReceived	12571	usd
CY2024Q1	us-gaap	Deferred Revenue DeferredRevenue	14252	usd
	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	543333	usd
	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	543333	usd
	us-gaap	Payments For Loans PaymentsForLoans	71000	usd
	us-gaap	Repayments Of Related Party Debt RepaymentsOfRelatedPartyDebt	25000	usd
	us-gaap	Current Federal Tax Expense Benefit CurrentFederalTaxExpenseBenefit	0	usd
CY2023	us-gaap	Current Federal Tax Expense Benefit CurrentFederalTaxExpenseBenefit	0	usd
	us-gaap	Current State And Local Tax Expense Benefit CurrentStateAndLocalTaxExpenseBenefit	0	usd
CY2023	us-gaap	Current State And Local Tax Expense Benefit CurrentStateAndLocalTaxExpenseBenefit	0	usd
	us-gaap	Current Income Tax Expense Benefit CurrentIncomeTaxExpenseBenefit	0	usd
CY2023	us-gaap	Current Income Tax Expense Benefit CurrentIncomeTaxExpenseBenefit	0	usd
	us-gaap	Deferred Federal Income Tax Expense Benefit DeferredFederalIncomeTaxExpenseBenefit	0	usd
CY2023	us-gaap	Deferred Federal Income Tax Expense Benefit DeferredFederalIncomeTaxExpenseBenefit	0	usd
	us-gaap	Deferred State And Local Income Tax Expense Benefit DeferredStateAndLocalIncomeTaxExpenseBenefit	0	usd
CY2023	us-gaap	Deferred State And Local Income Tax Expense Benefit DeferredStateAndLocalIncomeTaxExpenseBenefit	0	usd
	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	0	usd
CY2023	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	0	usd
	lbuy	Provision For Income Taxes ProvisionForIncomeTaxes	0	usd
CY2023	lbuy	Provision For Income Taxes ProvisionForIncomeTaxes	0	usd
CY2024Q1	us-gaap	Operating Loss Carryforwards OperatingLossCarryforwards	10728983	usd
CY2023Q2	us-gaap	Operating Loss Carryforwards OperatingLossCarryforwards	10728983	usd
CY2024Q1	lbuy	Other Temporary Differences OtherTemporaryDifferences	2306450	usd
CY2023Q2	lbuy	Other Temporary Differences OtherTemporaryDifferences	2306450	usd
CY2024Q1	us-gaap	Deferred Tax Assets Net DeferredTaxAssetsNet	13035433	usd
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Grants In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod	0	shares
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Grants In Period Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue	0.00
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Forfeitures Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue	0.00
CY2023Q2	us-gaap	Class Of Warrant Or Right Outstanding ClassOfWarrantOrRightOutstanding	29119898	shares
CY2023Q2	lbuy	Aggregate Intrinsic Value AggregateIntrinsicValue	0	usd
	us-gaap	Proceeds From Convertible Debt ProceedsFromConvertibleDebt	65000	usd
	lbuy	Debt Instruments Maturity Date DebtInstrumentsMaturityDate	120 days
	us-gaap	Debt Conversion Converted Instrument Rate DebtConversionConvertedInstrumentRate	0.12	pure

Files In Submission

Name	View Source	Status
0001477932-24-005855-index-headers.html	Edgar Link	pending
0001477932-24-005855-index.html	Edgar Link	pending
0001477932-24-005855.txt	Edgar Link	pending
0001477932-24-005855-xbrl.zip	Edgar Link	pending
Financial_Report.xlsx	Edgar Link	pending
lbuy-20240331.xsd	Edgar Link	pending
lbuy_10q.htm	Edgar Link	pending
lbuy_ex311.htm	Edgar Link	pending
lbuy_ex312.htm	Edgar Link	pending
lbuy_ex321.htm	Edgar Link	pending
lbuy_ex322.htm	Edgar Link	pending
MetaLinks.json	Edgar Link	pending
R1.htm	Edgar Link	pending
FilingSummary.xml	Edgar Link	unprocessable
lbuy-20240331_def.xml	Edgar Link	unprocessable
lbuy-20240331_pre.xml	Edgar Link	unprocessable
lbuy-20240331_lab.xml	Edgar Link	unprocessable
lbuy_10q_htm.xml	Edgar Link	completed
lbuy-20240331_cal.xml	Edgar Link	unprocessable
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
R41.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$LBUY
LEAFBUYER TECHNOLOGIES, INC. Stock $lbuy

2024 Q3 Form 10-Q Financial Statement

#000147793224005855 Filed on September 20, 2024

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$LBUY LEAFBUYER TECHNOLOGIES, INC. Stock $lbuy

2024 Q3 Form 10-Q Financial Statement

#000147793224005855 Filed on September 20, 2024

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$LBUY
LEAFBUYER TECHNOLOGIES, INC. Stock $lbuy